CardioScale

Improved Triage and Treatment for Trauma Victims

Health Tech & Life Sciences
Non Active, Nov 2025 ceased to operate

Company Overview

Snapshot

Founded in February 2012 by Maoz Ben - Ari and Uri Gabbay, CardioScale operates with 1–10 employees. The company has secured $100K in total capital across one funding round. In October 2019, its Cardiovascular Reserve Index (CVRI) calculator received CE Mark approval, a significant regulatory milestone for its medical device.

Business overview

CardioScale develops a solution for on-site deterioration prediction in trauma victims, aiming to improve triage and treatment prioritization. Its core technology is the DTR8, a portable cuff monitor that utilizes a proprietary algorithm and a cardiovascular reserve index (CVRI) to detect shock and pre-shock deterioration. This device measures vital signs and provides comprehensive results in under 60 seconds, transmitting data wirelessly to a handheld device. The company serves the healthcare and defense sectors, focusing on medical devices, digital healthcare, and patient remote monitoring.

Strategic signal

In October 2019, CardioScale's Cardiovascular Reserve Index (CVRI) calculator received CE Mark approval. This regulatory clearance is a critical signal for investors, validating the device's compliance with European health, safety, and environmental protection standards and indicating readiness for broader market adoption within the medical device industry.

Company Intelligence Q&A

What is CardioScale's primary product?
CardioScale's primary product is the DTR8, a portable cuff monitor designed for on-site deterioration prediction in trauma victims. It measures vital signs and uses a proprietary cardiovascular reserve index (CVRI) to detect shock and pre-shock conditions.
When was CardioScale founded?
CardioScale was founded in February 2012.
What significant regulatory approval did CardioScale receive?
In October 2019, CardioScale's Cardiovascular Reserve Index (CVRI) calculator received CE Mark approval, indicating its compliance with European standards.
What was a notable recognition CardioScale received in 2018?
In June 2018, CardioScale was among the winners announced in a Counter-Terrorism Startup Competition.
What was a notable recognition CardioScale received in 2018?
In June 2018, CardioScale was among the winners announced in a Counter-Terrorism Startup Competition.

External links